Mercury Labs' Financial Results Show Decline in Sales and Profitability
Mercury Laboratories, a microcap pharmaceutical company, reported its financial results for the quarter ending December 2023. The company's performance has remained flat with a slight improvement in its overall score. However, net sales have declined by 10.8% and Profit After Tax has shown a negative trend, leading to a 'Sell' call from MarketsMojo.
Mercury Laboratories, a microcap pharmaceutical company, recently announced its financial results for the quarter ending December 2023. According to the data released on February 12, 2024, the company's performance has remained flat compared to the previous quarter, with a slight improvement in its overall score from -5 to -4 in the last three months.
However, the company's net sales for the quarter have seen a decline of 10.8% at Rs 17.11 crore, compared to the average net sales of the previous four quarters which stood at Rs 19.19 crore. This indicates a negative trend in the company's near-term sales performance.
Moreover, Mercury Labs' Profit After Tax (PAT) for the nine-month period has shown a growth of -28.02% year on year (YoY) at Rs 3.75 crore. The near-term trend for PAT is also negative, indicating a decline in the company's profitability.
Based on these financial results, MarketsMOJO has given a 'Sell' call for Mercury Labs' stock. This means that the company's performance and financials do not meet the expectations of the market and investors are advised to sell their shares.
It is important to note that this news article is based on factual data and does not include any external opinions or recommendations from experts or investors. As a microcap company, Mercury Labs' financial performance may fluctuate and it is important for investors to make informed decisions based on the company's financials.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
